To improve the lives of heart failure patients and reduce healthcare costs by disrupting the cycle of hospitalization and readmissions and enabling and enhancing the opportunities for outpatient management of diuresis.

There are 6.5M adults in the U.S. with heart failure facing an increased risk of hospitalization and re-hospitalization. Currently, limited outpatient alternatives exist to effectively address increased congestion after the failure of oral treatment. We’re focused on developing a new model for treatment. 

It has been and remains the focused mission of scPharmaceuticals to develop and commercialize an outpatient diuretic therapy that is timely, convenient and has the potential to improve outcomes and quality of life.

In this pursuit, we are committed to supporting physicians, patients, caregivers and payors in reducing the systemic financial and physical constraints inherent in the highest-cost setting for the treatment of congestion due to worsening heart failure—the hospital.

Learn about our history

At scPharmaceuticals, we are committed to advancing outpatient care of acute conditions

To improve the lives of heart failure patients and reduce healthcare costs by disrupting the cycle of hospitalization and readmissions and enabling and enhancing the opportunities for outpatient management of diuresis.

There are 6.5M adults in the U.S. with heart failure facing an increased risk of hospitalization and re-hospitalization. Currently, limited outpatient alternatives exist to effectively address increased congestion after the failure of oral treatment. We’re focused on developing a new model for treatment. 

It has been and remains the focused mission of scPharmaceuticals to develop and commercialize an outpatient diuretic therapy that is timely, convenient and has the potential to improve outcomes and quality of life.

In this pursuit, we are committed to supporting physicians, patients, caregivers and payors in reducing the systemic financial and physical constraints inherent in the highest-cost setting for the treatment of congestion due to worsening heart failure—the hospital.

Learn about our history

At scPharmaceuticals, we are committed to advancing outpatient care of acute conditions